REFERENCES
*Omni Legend and Precision DL are CE marked. Omni Legend is 510(k)-cleared by the U.S. FDA. Precision DL is 510(k)-pending with the U.S. FDA. Not available for sale in the United States. Any clinical image shown that was processed with Precision DL was obtained from an investigational device, limited by U.S. law to investigational use.
- 1. Omni Legend 32 cm increases small lesion detectability 16% on average and up to 20%, as compared to Discovery MI 25 cm with matched scan time/injected dose, as demonstrated in phantom testing using a model observer with 4 mm lesions; average of different reconstruction methods.
- 2. Data on file.
- 3. Short life tracers such as Rubidium-82 used in PET cardiology scans. For dynamic protocols such as Whole Body Dynamic Acquisition, the Dynamic IQ processing application is required. Dynamic IQ is CE marked. It is 510(k)-pending with the U.S. FDA. Not cleared or approved by the U.S. FDA. Not for sale in the US.
- 4. Omni Legend 32 cm has up to 2.2 increase in system sensitivity as compared to Discovery MI 25 cm. Measurement follows NEMA NU 2-2018.
- 5. Up to 53% reduction of PET scan time on Omni Legend 32 cm compared to Discovery MI 25 cm, as demonstrated in phantom testing.
- 6. Up to 60% reduction in PET dose with Omni Legend 32 cm compared to Discovery MI 25 cm, as demonstrated in phantom testing.
- 7. The statement by the GE Healthcare customer described here is based on her own opinions and experiences and on results that were achieved in the customer’s unique setting. Since there is no typical hospital and many variables exist, such as hospital size, case mix, etc., there can be no guarantee that other customers will achieve the same results.